This study represents the first examination of how pharmaceutical industry representatives involved in marketing view the use of health outcome and pharmacoeconomic information by health care ...
Common study limitations include small sample sizes, loss to follow-up and other inherent issues upon which the pharmacoeconomic studies were based. From the perspective of emergency management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback